Dexamethasone Palmitate for PONV After Minimally Invasive Endoscopic Surgery

NARecruitingINTERVENTIONAL
Enrollment

588

Participants

Timeline

Start Date

June 17, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2026

Conditions
Postoperative Nausea and VomitingDexamethasone PalmitateMinimally Invasive Endoscopic Procedures
Interventions
DRUG

Dexamethasone palmitate

Patients in the dexamethasone palmitate group will be assigned to receive intravenous injection of dexamethasone palmitate 8 mg (contains 5mg dexamethasone) after anesthesia induction and before surgical incision.

DRUG

Dexamethasone

Patients in the dexamethasone group will be assigned to receive intravenous injections of dexamethasone 5 mg after anesthesia induction and before surgical incision.

Trial Locations (1)

100070

RECRUITING

Beijing Tiantan Hospital, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT06981754 - Dexamethasone Palmitate for PONV After Minimally Invasive Endoscopic Surgery | Biotech Hunter | Biotech Hunter